Shen, Y., Liang, X., Fang, T., Li, Y., Zhang, H., Zhou, H., Zhao, R., Tan, Q., Qin, A., Ding, J., Jia, W., Wu, T., Zhang, Y., Bai, X., Liang, T. (2025). Oncolytic virus VG161 in combination with camrelizumab as second-line therapy in patients with advanced primary hepatocellular carcinoma: A phase Ib/IIa clinical study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e14605